Literature DB >> 35747859

WHAT IS STRESS HYPERGLYCEMIA? A SUGGESTION FOR AN IMPROVEMENT OF ITS DEFINITION.

G Koraćević1,2, M Zdravković2.   

Abstract

Context: Stress hyperglycemia has been studied in numerous critical illnesses for several decades. Despite the extensive accumulation of knowledge about this topic, the definition of stress hyperglycemia is not updated since 2007. Subjects and
Methods: We performed a narrative review about stress hyperglycemia in acute myocardial infarction (AMI), aiming to improve its current definition and to give evidence supporting this.
Results: The definition of stress hyperglycemia in 2021 we recommend is: "SH is a high ABGly in an AMI patient irrespective of DM status. It can be calculated as e.g., "stress hyperglycemia ratio" or "admission glucose delta"/"glycemic gap". This definition may serve to start a consensus document of the experts in the field. The evidence accumulates supporting the possibility to recognize stress hyperglycemia also in AMI patients with diabetes mellitus (DM) by calculating glycemia during the previous 2-3 months using glycated hemoglobin. Moreover, it is now obvious that 2007 definition of stress hyperglycemia did not take into account the necessity to separate cut-offs for the subgroups with vs. without DM. Conclusions: We demonstrated the insufficiency of the current 2007 definition of stress hyperglycemia, provided evidence-based recommendation for the improvement and suggested the need for a consensus of the experts on this topic. In order to optimize the treatment of stress hyperglycemia in numerous critical illnesses, we ought to have its universal definition (as we already have the universal definition of AMI). ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  Stress hyperglycemia

Year:  2021        PMID: 35747859      PMCID: PMC9206148          DOI: 10.4183/aeb.2021.548

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  36 in total

1.  Using a single cut-off for stress hyperglycemia in myocardial infarction decreases its prognostic value particularly in diabetes.

Authors:  Goran P Koracevic
Journal:  Am J Emerg Med       Date:  2013-10-16       Impact factor: 2.469

2.  Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial.

Authors:  David Planer; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Ke Xu; Martin Fahy; Roxana Mehran; Gregg W Stone
Journal:  Int J Cardiol       Date:  2012-07-12       Impact factor: 4.164

3.  Stress hyperglycemia: better prognosticator with different cut-offs.

Authors:  Goran P Koracevic
Journal:  Am J Med       Date:  2013-05       Impact factor: 4.965

Review 4.  Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.

Authors:  S E Capes; D Hunt; K Malmberg; H C Gerstein
Journal:  Lancet       Date:  2000-03-04       Impact factor: 79.321

5.  Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy.

Authors:  Maarten de Mulder; Jan-Hein Cornel; Tjeerd van der Ploeg; Eric Boersma; Victor A Umans
Journal:  Am Heart J       Date:  2010-09       Impact factor: 4.749

6.  Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes.

Authors:  Qi Zhao; Ting-Yu Zhang; Yu-Jing Cheng; Yue Ma; Ying-Kai Xu; Jia-Qi Yang; Yu-Jie Zhou
Journal:  Curr Vasc Pharmacol       Date:  2021       Impact factor: 2.719

7.  Relative hyperglycemia is associated with complications following an acute myocardial infarction: a post-hoc analysis of HI-5 data.

Authors:  Tien F Lee; Morton G Burt; Leonie K Heilbronn; Arduino A Mangoni; Vincent W Wong; Mark McLean; N Wah Cheung
Journal:  Cardiovasc Diabetol       Date:  2017-12-12       Impact factor: 9.951

8.  Augmented glycaemic gap is a marker for an increased risk of post-infarct left ventricular systolic dysfunction.

Authors:  Yong Zhu; Kesen Liu; Shuai Meng; Ruofei Jia; Xuan Lei; Maolin Chen; Kaiyuan Zou; Huagang Zhu; Zening Jin
Journal:  Cardiovasc Diabetol       Date:  2020-07-04       Impact factor: 9.951

9.  Relationship between Random Blood Glucose, Fasting Blood Glucose, and Gensini Score in Patients with Acute Myocardial Infarction.

Authors:  Yuhan Qin; Gaoliang Yan; Yong Qiao; Changle Ma; Juchuan Liu; Chengchun Tang
Journal:  Biomed Res Int       Date:  2019-10-15       Impact factor: 3.411

10.  Translating the A1C assay into estimated average glucose values.

Authors:  David M Nathan; Judith Kuenen; Rikke Borg; Hui Zheng; David Schoenfeld; Robert J Heine
Journal:  Diabetes Care       Date:  2008-06-07       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.